Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants
Clinical trial NCT02832362 · COMPLETED
Trial details
- NCT number
- NCT02832362
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-11
- Primary completion
- 2016-07-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.